Diabetes Zentrum Wandsbek
Diabetes Zentrum Wandsbek is a Hamburg-based DDG-certified Diabetes Excellence Center providing comprehensive diagnosis, treatment, and structured education for all diabetes types, plus diabetic foot care and in-house clinical research.
- Company typePrivate
- Founded2010
- HeadquartersHamburg, Germany
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Diabetes Zentrum Wandsbek does
Diabetes Zentrum Wandsbek is a diabetological specialty practice (diabetologische Schwerpunktpraxis) headquartered at Wandsbeker Marktstraße 73 in Hamburg, Germany, operated as a Berufsausübungsgemeinschaft GbR partnership between Dr. med. Thorsten Koch and Dr. med. Nicole Koch since 2010 (Dr. Nicole Koch joined as co-owner in 2021). The practice delivers comprehensive diagnosis, therapy, and education across all diabetes types — Type 1, Type 2, gestational diabetes, prediabetes, and diabetic foot syndrome — through a multiprofessional team of 5 diabetologists, certified diabetes educators, GCP-trained study coordinators, and wound-care specialists, totaling approximately 20+ staff.
The service portfolio combines clinical care with structured education and research: diagnostic and therapy services (HbA1c, OGTT, CGM/FGM, insulin pump therapy including CSII/SuP/AID), a specialized diabetic foot outpatient clinic, 15+ structured diabetes courses (ICT, PRIMAS, INPUT, MEDIAS2, LINDA, HYPOS, SPECTRUM, PRAEDIAS), plus an in-house GCP-compliant clinical study center running Phase II–IV multi-center trials. The practice was certified as a DDG Diabetes Excellence Center in 2023 and has received the DDG Fußretter Award.
Revenue is generated primarily through German statutory and private health-insurance reimbursements under the DMP (Disease Management Program) framework for diabetes, supplemented by honoraria from participation in industry-sponsored clinical studies and ancillary fees (e.g., a €50 missed-appointment charge). Patient acquisition is referral-driven (Hausärzte) and reinforced by an active physician quality circle (Diabetes Forum Wandsbek), telemedicine/online-course channels, earned-media coverage (ZDF WISO, RTL, NDR), and a multilingual YouTube education library. The practice is independently physician-owned with no external capital or parent company.
Diabetes Zentrum Wandsbek firmographics
Firmographics- Name
- Diabetes Zentrum Wandsbek
- Legal name
- Diabetologische Schwerpunktpraxis Berufsausübungsgemeinschaft Dr. med. Thorsten Koch – Dr. med. Nicole Koch GbR
- Website
- https://hamburg-diabetes.de
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Diabetes Zentrum Wandsbek is a Hamburg-based DDG-certified Diabetes Excellence Center providing comprehensive diagnosis, treatment, and structured education for all diabetes types, plus diabetic foot care and in-house clinical research.
- Ownership category
- akta.pro rank
Diabetes Zentrum Wandsbek industry classification
Industry- Product category
- Diabetology / Diabetes Specialty Care
- NAICS
- Offices of Podiatrists (621391)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro industry
- Diabetes (General)Type 1 Diabetes CareType 2 Diabetes CareGestational Diabetes
Keywords
Where Diabetes Zentrum Wandsbek is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Diabetes Zentrum Wandsbek business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Treatment Services: Revenue generated from providing medical treatment services to patients. For statutory health insurance patients (gesetzlich Krankenversicherte), services are covered through the DMP (Disease Management Program) structure. Private insurance patients also covered. Specialized services like diabetes courses and diabetes consultations are fully covered for patients enrolled in the structured diabetes treatment program.
- Clinical Research Studies: Revenue from conducting international clinical multi-center studies (Phase II-IV) for new diabetes medications. Patients receive study compensation/honorarium for participation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | DMP-covered diabetes treatment for statutory health insurance patients |
| Subscription | Annual | Private insurance patient treatment |
| Other | Pay-as-you-go | Missed appointment fee |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Diabetes Zentrum Wandsbek product offering
Product offeringCore offering
Diabetes Zentrum Wandsbek is a diabetological specialty practice providing comprehensive diagnostics, therapy, and structured education for all forms of diabetes (Type 1, Type 2, gestational, prediabetes, and diabetic foot syndrome). The practice delivers outpatient medical care including continuous glucose monitoring, insulin pump therapy, wound care in a dedicated foot outpatient clinic, and 15+ structured patient education courses, and operates an in-house GCP-compliant clinical study center running international Phase II-IV trials for new diabetes medications.
Product overview
Diabetes Zentrum Wandsbek is a diabetological specialty practice (diabetologische Schwerpunktpraxis) offering a comprehensive, integrated portfolio of diabetes care services. The core offering centers on diagnostic and therapeutic services for all diabetes types, complemented by 15 structured diabetes courses and workshops (available as in-person or online), a specialized diabetic foot outpatient clinic (Diabetische Fußambulanz), and a GCP-compliant clinical research center. Additional services include general diagnostics (EKG, BIA, 24-hour blood pressure monitoring), vaccination services, and psychosocial care. The practice operates a YouTube channel with multilingual explainer videos and offers video/telephone consultations for patient convenience. Services are delivered through a multiprofessional team of diabetologists, diabetes counselors, study coordinators, wound care specialists, and support staff.
Differentiator
Problem solved
Functional benefit
Products and services
- Diagnostik und Therapie aller Diabetesformen (Diagnostics and Therapy for All Diabetes Types) Comprehensive outpatient diagnostics and therapy for all forms of diabetes mellitus, including HbA1c and blood glucose rapid diagnostics, oral glucose tolerance testing, genetic diabetes examination, microalbumin determination, polyneuropathy and gastroparesis diagnostics, hypoglycemia diagnostics, continuous glucose monitoring (FGM, rt-CGM), and insulin pump therapy (CSII, SuP, AID). Targeted at patients with any type of diabetes referred by primary care physicians.
- Diabeteskurse und Workshops (Structured Diabetes Education Courses) Portfolio of 15 structured diabetes education programs adapted to diabetes type, therapy, and patient situation, including ICT training, PRIMAS, INPUT, HYPOS for Type 1; MEDIAS2, OAD, CT/BOT, LINDA for Type 2; and specialized courses for pregnancy diabetes, prediabetes (PRAEDIAS), and Nordic Walking. Delivered as in-person or online courses for enrolled patients.
- Diabetische Fußambulanz (Diabetic Foot Outpatient Clinic) Specialized outpatient clinic for diabetic foot syndrome offering preventive treatment, Doppler occlusion pressure measurement, wound and dressing management, pressure-relieving therapy (including total contact casting), antibiotic therapy, and foot-specific patient education. Coordinated with orthopedic shoemakers, vascular surgeons, neurologists, radiologists, dermatologists, and podologists.
- Disease Management Programm (DMP) für Diabetes Structured treatment program for chronically ill diabetes patients as defined by German health insurance regulations, enabling high-quality specialized treatment including evaluated diabetes courses and diabetes counseling, with full coverage for statutory health insurance enrollees.
- Klinische Diabetesforschung (Clinical Diabetes Research) GCP-compliant clinical study center conducting international multi-center clinical trials (Phase II-IV) examining therapeutic efficacy, dose-finding, and long-term effects of new diabetes medications and combination preparations. Patients receive study honoraria for participation.
Quantifiable outcome
- Average new patient wait time reduced to 6 working days (2011-2022)
- +3 more outcomes
Companies that use Diabetes Zentrum Wandsbek
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Diabetes Zentrum Wandsbek technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Diabetes Zentrum Wandsbek partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Cardiologicum HamburgcoreCardiology partnership for cardiovascular assessment and care of diabetic patients with heart conditions
- Nephrologie MVZ Diaverum Alter TeichwegcoreNephrology partnership for kidney disease screening and management in diabetic patients
- Augenarzt Hamburg Dr. Thomas BegallcoreOphthalmology partnership for diabetic eye disease screening and treatment
- Neurologin Dr. RazaicoreNeurology partnership for diabetic neuropathy diagnosis and management
- Orthopädieschuhtechnik Trenntmann-GromotkacoreOrthopedic shoemaking partnership for diabetic foot footwear solutions
- Podologin Frau RobertsoncoreMedical podiatry partnership for diabetic foot care
- Psychotherapeutin Dr. WeymannminorPsychotherapy partnership for diabetes-related psychological support
- Chirurgen Drs. Schütze und LangensteincoreSurgical partnership for diabetic foot interventions and surgeries
- Asklepios Klinik Wandsbek GefäßchirurgiecoreVascular surgery partnership at Asklepios Clinic Wandsbek for diabetic vascular disease treatment
- Gynäkologin Dr. KöllncoreGynecology partnership for gestational diabetes management and pregnancy care
- Kinderarzt Dr. SchultzminorPediatric partnership for childhood diabetes care coordination
- Radiologie SchlossgartencoreRadiology partnership for diagnostic imaging services
- Labor LademannbogencoreLaboratory partnership for clinical diagnostic testing
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Diabetes Zentrum Wandsbek competitors and assessment
Company assessmentEmerging players
- mySugr (Roche): Digital diabetes self-management platform acquired by Roche; comparable as a diabetes self-management solution targeting the same patient segments, though delivered via app rather than in-person specialty practice.
Broad incumbents
- DDZ - German Diabetes Center Düsseldorf: Leibniz Center for Diabetes Research at Heinrich Heine University; comparable as a leading German institution integrating diabetes clinical research, outpatient care, and structured patient education.
- Joslin Diabetes Center: Harvard-affiliated US diabetes specialty and research center; comparable as an academic-grade diabetes treatment facility offering integrated care, education, and clinical research across all diabetes types.
- Steno Diabetes Center Copenhagen: Large specialized diabetes treatment and research center operated by Novo Nordisk Foundation; comparable as a high-acuity, multidisciplinary diabetes care center combining clinical practice, research, and patient education, though at materially larger scale than a single German practice.
Direct peers
- Diabetes-Zentrum Quakenbrück: German diabetes specialty center offering comprehensive diabetology services across all diabetes types; directly comparable as a specialist diabetes practice operating in the German DMP framework with similar multiprofessional team structure.
- Diabetes-Zentrum am St. Josefskrankenhaus Heidelberg: Hospital-affiliated German diabetes specialty center offering comprehensive diagnostic, therapeutic, and educational services across all diabetes types; directly comparable in clinical scope and DMP participation.
- Diabetes-Zentrum Bad Mergentheim: Mid-sized German diabetology center offering integrated diabetes care, education programs, and clinical research; comparable as a multiprofessional specialty practice operating under the same DDG quality framework.
Regional players
- Diabetes-Zentrum Münster: Regional German diabetes specialty center providing multiprofessional care, structured education (DMP), and complication management; directly comparable practice model in a different German metropolitan catchment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Diabetes Zentrum Wandsbek social profiles
Digital presenceDiabetes Zentrum Wandsbek financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diabetes Zentrum Wandsbek leadership team
Management profileNumber of profiles
Profiles7 records
Diabetes Zentrum Wandsbek funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diabetes Zentrum Wandsbek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diabetes Zentrum Wandsbek
What does Diabetes Zentrum Wandsbek do?
Diabetes Zentrum Wandsbek is a diabetological specialty practice providing comprehensive diagnostics, therapy, and structured education for all forms of diabetes (Type 1, Type 2, gestational, prediabetes, and diabetic foot syndrome). The practice delivers outpatient medical care including continuous glucose monitoring, insulin pump therapy, wound care in a dedicated foot outpatient clinic, and 15+ structured patient education courses, and operates an in-house GCP-compliant clinical study center running international Phase II-IV trials for new diabetes medications.
Is Diabetes Zentrum Wandsbek a public or private company?
Diabetes Zentrum Wandsbek is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Diabetes Zentrum Wandsbek founded?
Diabetes Zentrum Wandsbek was founded in 2010. It employs 1 to 10 people.
Where is Diabetes Zentrum Wandsbek based?
Diabetes Zentrum Wandsbek is headquartered in Hamburg, Germany, in the Europe region.
How does Diabetes Zentrum Wandsbek make money?
Two revenue lines are on record. Medical Treatment Services are the primary driver. The others are clinical Research Studies.
Who are Diabetes Zentrum Wandsbek's main competitors?
mySugr (Roche) is listed as an emerging player. Broad incumbents are DDZ - German Diabetes Center Düsseldorf, Joslin Diabetes Center and Steno Diabetes Center Copenhagen. Direct peers are Diabetes-Zentrum Quakenbrück, Diabetes-Zentrum am St. Josefskrankenhaus Heidelberg and Diabetes-Zentrum Bad Mergentheim. Diabetes-Zentrum Münster is listed as a regional player.
Does Diabetes Zentrum Wandsbek have an API?
No public API is recorded for Diabetes Zentrum Wandsbek.
What industry is Diabetes Zentrum Wandsbek in?
Diabetes Zentrum Wandsbek's product category is Diabetology / Diabetes Specialty Care. Its primary akta.pro industry code is HLAKADAA, Diabetes (General), with a secondary code of HLAKADAB, Type 1 Diabetes Care. Its NAICS code is 621391 and its SIC code is 8011.